SONG Yi-Fan , CHEN Li-Ting , ZHANG Chao , REN Ye-Ping , WANG Qin . Leukemia patients with severe iron overload and treated with double filtration plasmapheresis: report of two cases and review of the literature[J]. Chinese Journal of Blood Purification, 2024 , 23(11) : 878 -880 . DOI: 10.3969/j.issn.1671-4091.2024.11.016

[1]中国医师协会血液科医师分会中华医学会血液学分会.铁过载诊断与治疗的中国专家共识[J].中华血液学杂志, 2011, 32(8):572-574
[2]ITALIA K, COLAH R, GHOSH K.Experimental animal model to study iron overload and iron chelation and review of other such models[J].Blood Cells Mol Dis, 2015, 55(3):194-199
[3]SHENOY N, VALLUMSETLA N, RACHMILEWITZ E, et al.Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome[J].Blood, 2014, 124(6):873-881
[4]HANDA P, MORGAN-STEVENSON V, MALIKEN B D, et al.Iron overload results in hepatic oxidative stress,immune cell activation,and hepatocellular ballooning injury,leading to nonalcoholic steatohepatitis in genetically obese mice[J].Am J Physiol Gastrointest Liver Physiol, 2016, 310(2):G117-G127
[5]PIPERNO A, PELUCCHI S, MARIANI R.Inherited iron overload disorders[J].Transl Gastroenterol Hepatol, 2020, 5(25):-
[6]CAPPELLINI M D, PORTER J, EL-BESHLAWY A, et al.Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias[J].Haematologica, 2010, 95(4):557-566
[7]BRAMLAGE C P, ARMSTRONG V W, ZAPF A, et al.Low-density lipoprotein apheresis decreases ferritin,transferrin and vitamin B12,which may cause anemia in serially treated patients[J].Ther Apher Dial, 2010, 14(2):136-142
[8]BASAR R, UZUM A K, CANBAZ B, et al.Therapeutic apheresis for severe hypertriglyceridemia in pregnancy[J].Arch Gynecol Obstet, 2013, 287(5):839-843
[9]BIER-ULRICH A M, HAUBELT H, ANDERS C, et al.The impact of intensive serial plasmapheresis and iron supplementation on iron metabolism and Hb concentration in menstruating women: a prospective randomized placebo-controlled double-blind study[J].Transfusion, 2003, 43(3):405-410
[10]GRADY R W, GALANELLO R, RANDOLPH R E, et al.Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine[J].Haematologica, 2013, 98(1):129-135
[11]De SANCTIS V, SOLIMAN A, YASSIN M.Iron overload and glucose metabolism in subjects with beta-thalassaemia major: an overview[J].Curr Diabetes Rev, 2013, 9(4):332-341
[12]CHUNG W S, LIN C L, LIN C L, et al.Thalassaemia and risk of cancer: a population-based cohort study[J].J Epidemiol Community Health, 2015, 69(11):1066-1070
[13]GIESBRANDT K J, BOLAN C W, SHAPIRO B P, et al.Diffuse diseases of the myocardium: MRI-pathologic review of cardiomyopathies with dilatation[J].AJR Am J Roentgenol, 2013, 200(3):W274-W282
[14]BUJA L M, ROBERTS W C.Iron in the heartEtiology and clinical significance[J].Am J Med, 1971, 51(2):209-221
[15]TAHER A T, CAPPELLINI M D.How I manage medical complications of beta-thalassemia in adults[J].Blood, 2018, 132(17):1781-1791
[16]MEERPOHL J J, SCHELL L K, RUCKER G, et al.Deferasirox for managing iron overload in people with myelodysplastic syndrome[J].Cochrane Database Syst Rev, 2014, 2014(10):D7461-
[17]ALESSANDRINO E P, DELLA P M, BACIGALUPO A, et al.Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study[J].Haematologica, 2010, 95(3):476-484
[18]DAVIS B A, PORTER J B.Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia[J].Blood, 2000, 95(4):1229-1236
[19]MUSALLAM K M, TAHER A T.Iron-chelating therapy for transfusional iron overload[J].N Engl J Med, 2011, 364(15):1476-
[20]LYONS R M, MAREK B J, PALEY C, et al.Comparison of 24-month outcomes in chelated and non-chelated lower-risk patients with myelodysplastic syndromes in a prospective registry[J].Leuk Res, 2014, 38(2):149-154
[21]NEUKIRCHEN J, FOX F, KUNDGEN A, et al.Improved survival in MDS patients receiving iron chelation therapy - a matched pair analysis of 188 patients from the Dusseldorf MDS registry[J].Leuk Res, 2012, 36(8):1067-1070
[22]ROSE C, BRECHIGNAC S, VASSILIEF D, et al.Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM (Groupe Francophone des Myelodysplasies)[J].Leuk Res, 2010, 34(7):864-870
[23]YEH J H, CHEN W H, CHIU H C, et al.Clearance studies during subsequent sessions of double filtration plasmapheresis[J].Artif Organs, 2006, 30(2):111-114
[24]YEH J H, CHEN W H, CHIU H C.Complications of double-filtration plasmapheresis[J].Transfusion, 2004, 44(11):1621-1625